Vaccine against cervical cancer ‘100% effective’

A CONTROVERSIAL vaccine against cervical cancer could be available within a year following dramatic trial results which proved 100% effective at preventing the precursor changes that signal the disease.

A total of 12,167 women aged 16 to 23 from 13 countries took part in the trial of the drug, Gardasil.

Half were given three injections of Gardasil spanning six months and half jabs of an inactive dummy drug. They were then monitored for an average of two years.